Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, de Morais, J, Sola, S and Sedefov, R (2017) Technical report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA). Annex 1 to the Risk Assessment Report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3- carboxamide (CUMYL-4CN-BINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, de Morais, J, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Annex 1 to the Risk Assessment Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2- carboxamide (tetrahydrofuranylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.